12-5045296-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002234.4(KCNA5):​c.1149T>C​(p.Gly383Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.985 in 152,302 control chromosomes in the GnomAD database, including 73,946 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G383G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.99 ( 73946 hom., cov: 33)
Exomes 𝑓: 1.0 ( 728612 hom. )
Failed GnomAD Quality Control

Consequence

KCNA5
NM_002234.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -5.24

Publications

14 publications found
Variant links:
Genes affected
KCNA5 (HGNC:6224): (potassium voltage-gated channel subfamily A member 5) Potassium channels represent the most complex class of voltage-gated ino channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, the function of which could restore the resting membrane potential of beta cells after depolarization and thereby contribute to the regulation of insulin secretion. This gene is intronless, and the gene is clustered with genes KCNA1 and KCNA6 on chromosome 12. Defects in this gene are a cause of familial atrial fibrillation type 7 (ATFB7). [provided by RefSeq, May 2012]
KCNA5 Gene-Disease associations (from GenCC):
  • atrial fibrillation, familial, 7
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 12-5045296-T-C is Benign according to our data. Variant chr12-5045296-T-C is described in ClinVar as Benign. ClinVar VariationId is 258594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNA5NM_002234.4 linkc.1149T>C p.Gly383Gly synonymous_variant Exon 1 of 1 ENST00000252321.5 NP_002225.2 P22460-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNA5ENST00000252321.5 linkc.1149T>C p.Gly383Gly synonymous_variant Exon 1 of 1 6 NM_002234.4 ENSP00000252321.3 P22460-1

Frequencies

GnomAD3 genomes
AF:
0.985
AC:
149929
AN:
152184
Hom.:
73890
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.950
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.993
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.996
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.990
GnomAD2 exomes
AF:
0.996
AC:
250415
AN:
251388
AF XY:
0.997
show subpopulations
Gnomad AFR exome
AF:
0.952
Gnomad AMR exome
AF:
0.998
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
0.995
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.998
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.998
AC:
1459505
AN:
1461882
Hom.:
728612
Cov.:
100
AF XY:
0.999
AC XY:
726203
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.950
AC:
31792
AN:
33480
American (AMR)
AF:
0.997
AC:
44612
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26136
AN:
26136
East Asian (EAS)
AF:
0.994
AC:
39466
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86244
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53408
AN:
53408
Middle Eastern (MID)
AF:
0.997
AC:
5749
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111917
AN:
1112012
Other (OTH)
AF:
0.996
AC:
60181
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
178
356
533
711
889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21670
43340
65010
86680
108350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.985
AC:
150044
AN:
152302
Hom.:
73946
Cov.:
33
AF XY:
0.986
AC XY:
73442
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.950
AC:
39485
AN:
41574
American (AMR)
AF:
0.993
AC:
15200
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
0.996
AC:
5110
AN:
5130
South Asian (SAS)
AF:
1.00
AC:
4828
AN:
4830
European-Finnish (FIN)
AF:
1.00
AC:
10628
AN:
10628
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68021
AN:
68034
Other (OTH)
AF:
0.990
AC:
2095
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
111
223
334
446
557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.996
Hom.:
8365
Bravo
AF:
0.983
Asia WGS
AF:
0.995
AC:
3462
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 95. Only high quality variants are reported. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Atrial fibrillation, familial, 7 Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.22
DANN
Benign
0.42
PhyloP100
-5.2
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2359641; hg19: chr12-5154462; COSMIC: COSV108046922; API